274 Chapter 11 References 1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801-10. 2. Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. Jama. 2014;312(1):90-2. 3. Prescott HC, Osterholzer JJ, Langa KM, Angus DC, Iwashyna TJ. Late mortality after sepsis: propensity matched cohort study. BMJ (Clinical research ed). 2016;353:i2375. 4. Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ (Clinical research ed). 2016;353:i1585. 5. Calfee CS. Opening the Debate on the New Sepsis Definition. Precision Medicine: An Opportunity to Improve Outcomes of Patients with Sepsis. American journal of respiratory and critical care medicine. 2016;194(2):137-9. 6. van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nature reviews Immunology. 2017;17(7):407-20. 7. Tziolos N, Giamarellos-Bourboulis EJ. Contemporary approaches to the rapid molecular diagnosis of sepsis. Expert Rev Mol Diagn. 2016;16(11):1201-7. 8. Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clinical microbiology reviews. 2010;23(1):235-51. 9. Opota O, Jaton K, Greub G. Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood. Clin Microbiol Infect. 2015;21(4):323-31. 10. Dien Bard J, McElvania TeKippe E. Diagnosis of Bloodstream Infections in Children. Journal of clinical microbiology. 2016;54(6):1418-24. 11. Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, et al. Sepsis: a roadmap for future research. The Lancet Infectious diseases. 2015;15(5):581-614. 12. Banerjee R, Ozenci V, Patel R. Individualized Approaches Are Needed for Optimized Blood Cultures. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016;63(10):1332-9. 13. Kothari A, Morgan M, Haake DA. Emerging technologies for rapid identification of bloodstream pathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;59(2):272-8. 14. Dubourg G, Raoult D. Emerging methodologies for pathogen identification in positive blood culture testing. Expert Rev Mol Diagn. 2016;16(1):97-111. 15. Mwaigwisya S, Assiri RA, O’Grady J. Emerging commercial molecular tests for the diagnosis of bloodstream infection. Expert Rev Mol Diagn. 2015;15(5):681-92. 16. Palavecino EL. Rapid methods for detection of MRSA in clinical specimens. Methods Mol Biol. 2014;1085:71-83. 17. Opota O, Croxatto A, Prod’hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. 2015;21(4):313-22. 18. Buchan BW, Allen S, Burnham CA, McElvania TeKippe E, Davis T, Levi M, et al. Comparison of the next-generation Xpert MRSA/SA BC assay and the GeneOhm StaphSR assay to routine culture for identification of Staphylococcus aureus and methicillin-resistant S. aureus in positive-blood-culture broths. Journal of clinical microbiology. 2015;53(3):804-9. 19. Scott JS, Sterling SA, To H, Seals SR, Jones AE. Diagnostic performance of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry in blood bacterial infections: a systematic review and meta-analysis. Infect Dis (Lond). 2016;48(7):530-6. 20. Galiana A, Coy J, Gimeno A, Guzman NM, Rosales F, Merino E, et al. Evaluation of the Sepsis Flow Chip assay for the diagnosis of blood infections. PloS one. 2017;12(5):e0177627.
RkJQdWJsaXNoZXIy MTk4NDMw